MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$57,591K
EPS
-$2.93
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
48,936
General and administrative
13,789
Credit loss - related party accounts receivable
0
Total operating expenses
62,725
Loss from operations
-62,725
Unrealized loss on short-term investments
-5
Interest and dividend income
5,139
Total other income, net
5,134
Net loss
-57,591
Basic EPS
-2.93
Diluted EPS
-2.93
Basic Average Shares
19,624,626
Diluted Average Shares
19,624,626
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest and dividendincome$5,139K Net loss-$57,591K Total other income,net$5,134K Unrealized loss onshort-term investments-$5K Loss from operations-$62,725K Total operatingexpenses$62,725K Research and development$48,936K General andadministrative$13,789K

Aardvark Therapeutics, Inc. (AARD)

Aardvark Therapeutics, Inc. (AARD)